Cognitive Function After Radiation Therapy for Brain Tumours
WP-12-pre
1 other identifier
observational
104
1 country
1
Brief Summary
This study will assess cognitive function in adult patients with a primary brain tumour treated with surgical resection with or without radiation therapy (RT). All types of brain tumours apart from glioblastoma will be included
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 7, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 12, 2018
CompletedFirst Submitted
Initial submission to the registry
June 1, 2018
CompletedFirst Posted
Study publicly available on registry
October 8, 2019
CompletedOctober 10, 2019
October 1, 2019
12 months
June 1, 2018
October 7, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Memory impairment (as assessed by the HVLT-r)
To examine the correlation between memory impairment (assessed by HVLT-r) and mean dose to the hippocampus.
1-10 years after treatment
Neurocognitive function
Examine correlations cognitive decline and subvolumes of the brain. Cognitive function will be assessed by standardized cognitive tests: Hopkins verbal learning test (HVLT), Trail Making Test part A and B (TMT A and TMT B), Pased Auditory Test (PASAT), Wechsler Adult Intelligence Scale coding and digit span (WAIS-IV), Controlled Oral Word Association Test (Cowat) and STROOP colour and word test (STROOP). Measures on cognitive test is time in seconds or number of "corrects".
1-10 years after treatment
Secondary Outcomes (5)
Global Health - Quality of life
1-10 years after treatment
Fatigue
1-10 years after treatment
Sleep quality
1-10 years after treatment
Depression/Anxiety
1-10 years after treatment
Patients assessment of own cognitive function
1-10 years after treatment
Study Arms (2)
Radiotherapy group
Patients receiving radiotherapy after surgery for brain tumor
No radiotherapy group
Patients NOT receiving radiotherapy after surgery for brain tumor
Interventions
Patients will have their cognitive function tested by the use of standardized cognitive test and fill in questionnaires. Cognitive function will be assessed by standardized cognitive tests: Hopkins verbal learning test (HVLT), Trail Making Test part A and B (TMT A and TMT B), Pased Auditory Test (PASAT), Wechsler Adult Intelligence Scale coding and digit span (WAIS-IV), Controlled Oral Word Association Test (Cowat) and STROOP colour and word test (STROOP) Questionnaire include; Quality of life; EORTC QlQ-C30 (QlQ-C30), FACIT-Fatigue Scale (Version 4) (FACIT), Pittsburg Sleep Quality Index (PSQI), Hospital Anxiety and Depression Scale (HADS), Patient's Assessment of Own Functioning Inventory (PAOFI).
Eligibility Criteria
Adults with a primary brain tumour grade I-III
You may qualify if:
- The participant must be 18 years or older and Danish speaking.
- Performance status 0-2
- Capable of cooperating on testing
- Diagnosed with one of the following diagnoses according to WHO 2016 classification 16 and been treated between 2006 and 2016
- ZM93803 glioma (exclusive glioblastoma)
- ZM9401/3 anaplastic astrocytoma, IDH mutant
- ZM9400/3 diffuse astrocytoma, IDH-mutant
- ZM9411/3 gemistocytisk astrocytoma, IDH mutant
- ZM9400/3 diffuse astrocytoma, NOS
- ZM9451/3 anaplastic oligodendroglioma, IDH mutant and 1p/19q-co deleted
- ZM9450/3 oligodendroglioma, IDH mutant and 1p/19q-co deleted
- ZM9450/3 oligodendroglioma, NOS
- ZM9451/3 anaplastic oligodendroglioma, NOS
- ZM9530/0 meningioma
- ZM9470/3 medulloblastoma, NOS
- +2 more criteria
You may not qualify if:
- Performance status 3-4 Progression after radiation therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aarhus University Hospital
Aarhus, Region Midt, 8000, Denmark
Related Publications (1)
Haldbo-Classen L, Amidi A, Lukacova S, Wu LM, Oettingen GV, Lassen-Ramshad Y, Zachariae R, Kallehauge JF, Hoyer M. Cognitive impairment following radiation to hippocampus and other brain structures in adults with primary brain tumours. Radiother Oncol. 2020 Jul;148:1-7. doi: 10.1016/j.radonc.2020.03.023. Epub 2020 Mar 28.
PMID: 32298906DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Morten Høyer, M.D.
Aarhus University Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 1, 2018
First Posted
October 8, 2019
Study Start
February 7, 2017
Primary Completion
February 2, 2018
Study Completion
April 12, 2018
Last Updated
October 10, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share